Cargando…

First person – Kaitly Woodard

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease con...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277143/
http://dx.doi.org/10.1242/dmm.049644
_version_ 1784745887536250880
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations’, published in DMM. Kaitly conducted the research described in this article while a graduate student in Mitchell J. Weiss's lab at St. Jude Children's Research Hospital, Memphis, TN, USA. She is now a Senior Scientist II in the lab of Mir Hossain at Novartis Institutes for BioMedical Research, Cambridge, MA, USA, investigating gene therapy for haemoglobinopathies.
format Online
Article
Text
id pubmed-9277143
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-92771432022-07-13 First person – Kaitly Woodard Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Kaitly Woodard is first author on ‘ Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations’, published in DMM. Kaitly conducted the research described in this article while a graduate student in Mitchell J. Weiss's lab at St. Jude Children's Research Hospital, Memphis, TN, USA. She is now a Senior Scientist II in the lab of Mir Hossain at Novartis Institutes for BioMedical Research, Cambridge, MA, USA, investigating gene therapy for haemoglobinopathies. The Company of Biologists Ltd 2022-07-07 /pmc/articles/PMC9277143/ http://dx.doi.org/10.1242/dmm.049644 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Kaitly Woodard
title First person – Kaitly Woodard
title_full First person – Kaitly Woodard
title_fullStr First person – Kaitly Woodard
title_full_unstemmed First person – Kaitly Woodard
title_short First person – Kaitly Woodard
title_sort first person – kaitly woodard
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277143/
http://dx.doi.org/10.1242/dmm.049644